Fairmount Funds Management LLC's most recent trades

Director, 10% Owner, See Remarks

%

COMPANY

SHARES

NET TOTAL

9.91%

BIOHAVEN PHARMACTL HLDG CO

264,206

$38,497,000.00

9.30%

AXSOME THERAPEUTICS INC

942,571

$36,100,000.00

9.11%

BIOCRYST PHARMACEUTICALS INC

3,343,107

$35,370,000.00

7.84%

GLOBAL BLOOD THERAPEUTICS IN

953,396

$30,461,000.00

7.17%

73,526

$27,858,000.00

7.10%

NEUROCRINE BIOSCIENCES INC

283,000

$27,587,000.00

6.74%

1,326,368

$26,156,000.00

6.41%

COGENT BIOSCIENCES INC

2,758,975

$24,886,000.00

5.71%

ENANTA PHARMACEUTICALS INC

469,264

$22,182,000.00

4.64%

111,400

$18,030,000.00

3.45%

CTI BIOPHARMA CORP

2,245,891

$13,408,000.00

3.17%

DBV TECHNOLOGIES SA

4,831,155

$12,319,000.00

2.81%

VIRIDIAN THERAPEUTICS INC

944,092

$10,923,000.00

2.81%

2,892,600

$10,905,000.00

2.80%

OLEMA PHARMACEUTICALS INC

2,669,300

$10,864,000.00

2.73%

ACADIA PHARMACEUTICALS INC

751,804

$10,593,000.00

2.14%

AMARIN CORP PLC

5,584,837

$8,321,000.00

1.94%

KEROS THERAPEUTICS INC

272,498

$7,529,000.00

1.18%

TREVI THERAPEUTICS INC

1,624,389

$4,565,000.00

1.11%

IOVANCE BIOTHERAPEUTICS INC

389,588

$4,301,000.00

1.00%

VERONA PHARMA PLC

926,602

$3,882,000.00

0.80%

673,905

$3,113,000.00

0.12%

147,189

$461,000.00